Plasma lipoprotein distribution of apolipoprotein E: the quantitative significance of apo E in remnant-sized lipoproteins in normolipidemic and hyperlipidemic subjects

1994 ◽  
Vol 109 (1-2) ◽  
pp. 221-222
Author(s):  
J.S. Cohn ◽  
M. Tremblay ◽  
H. Jacques ◽  
M. Amiot ◽  
D. Bouthillier ◽  
...  
Author(s):  
J C Gibson ◽  
R B Goldberg ◽  
A Rubinstein ◽  
H N Ginsberg ◽  
W V Brown ◽  
...  

1999 ◽  
Vol 144 ◽  
pp. 128
Author(s):  
B. Le Roy ◽  
A. Ruelland ◽  
F. Sayed ◽  
A. Thaminy ◽  
V. Bordeau ◽  
...  

Author(s):  
Lanny C. Gultom ◽  
Damayanti R. Sjarif ◽  
Herawati A. Sudoyo ◽  
Muchtaruddin Mansyur ◽  
Sri Rezeki S. Hadinegoro ◽  
...  

AbstractLifestyle changes are important factors for managing dyslipidemia before considering blood lipid-lowering drugs. However, genetic factors can influence the response outcome.We aimed to determine a dyslipidemia management strategy in obese adolescents.: A total of 60 dyslipidemic obese adolescents received physical exercise and the NCEP step II diet for 28 days. Apolipoprotein E (apo E) genotypes and blood lipid levels were compared before and after interventions.The apoApo E alleles might influence improvement in lipid profiles after diet and exercise interventions. These results could inform personalized dyslipidemia management in obese adolescents, to determine which subjects would benefit from blood lipid-lowering drugs.


1999 ◽  
Vol 9 (2) ◽  
pp. 163-182 ◽  
Author(s):  
DWK Kay

The last five years have produced a large output on the epidemiology of dementia and cognitive impairment, specially on apolipoprotein E (apo E), vascular changes, and education as risk factors. Minor cognitive deficits have been studied prospectively to assess their value in predicting dementia. Reviews of work from particular centres and articles on special aspects give more detail. Preference is given to population-based over clinic-based studies and to those published in or after 1994.


Sign in / Sign up

Export Citation Format

Share Document